IMPROVING THE PROGNOSTIC VALUE OF DNA FLOW-CYTOMETRY IN METASTATIC MELANOMA BY COMBINING PLOIDY AND S-PHASE FRACTION

被引:2
|
作者
MUHONEN, T
机构
[1] Department of Radiotherapy and Oncology, Helsinki University Central Hospital, Helsinki, SF-00290
关键词
DNA; FLOW CYTOMETRY; MELANOMA; MELANOMA MORTALITY; PLOIDY; S-PHASE FRACTION;
D O I
10.1097/00008390-199211000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic value of cellular DNA content of melanoma metastases was investigated in tumours from 114 consecutive patients referred to the Helsinki University Central Hospital Melanoma Team. Thirty-six percent of the tumours were diploid and 64% aneuploid. For 91 patients the S-phase fraction was calculable. Tumour ploidy and S-phase fraction (SPF) were shown by multivariate Cox model analysis to be independent prognostic variables and major determinants of survival after first recurrence. Patients with either aneuploid or low SPF tumours survived longer than did those with diploid or high SPF tumours. By combining DNA ploidy and SPF, three types of DNA histograms could be defined, associated with favourable, intermediate and poor prognosis. Patients with aneuploid, low SPF metastases showed a median survival of 57 months, whereas the high-risk group with diploid, high SPF metastases survived only 13 months. When ploidy, SPF, age, sex, TNM stage and duration of disease-free survival were analysed as covariates the division of flow cytometry histograms into these three types resulted in the most significant prognostic factor (p<0.001) in the Cox multivariate analysis.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 50 条
  • [31] QUALITY-CONTROL FOR EVALUATION OF THE S-PHASE FRACTION BY FLOW-CYTOMETRY - A MULTICENTRIC STUDY
    SILVESTRINI, R
    LUISI, A
    DAIDONE, MG
    COSTA, A
    VALENTINIS, B
    ZUPI, G
    DAGNANO, I
    GEIDO, E
    GIARETTI, W
    PEPE, S
    RUGGIERO, A
    RUSSO, A
    BAZAN, V
    FACCHINI, A
    LALLI, E
    MAZZINI, G
    UNGARI, S
    RIBA, S
    CYTOMETRY, 1994, 18 (01): : 11 - 16
  • [32] PROGNOSTIC-SIGNIFICANCE OF DNA-PLOIDY AND S-PHASE FRACTION IN COLORECTAL ADENOCARCINOMA
    SUN, XF
    CARSTENSEN, JM
    STAL, O
    WINGREN, S
    HATSCHEK, T
    ZHANG, H
    NORDENSKJOLD, B
    DIAGNOSTIC ONCOLOGY, 1993, 3 (03): : 121 - 126
  • [33] Ploidy analysis and S-phase fraction determination by flow cytometry in anembryonic pregnancy and spontaneous abortions
    Özeren, M
    Aydemir, V
    Tekelioglu, Y
    Topçuoglu, K
    Bozkaya, H
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1999, 48 (02) : 104 - 107
  • [34] Prognostic significance of DNA ploidy and S-phase fraction in malignant serous cystadenocarcinoma of the ovary
    Bakshi, N
    Rajwanshi, A
    Patel, F
    Ganguly, NK
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1998, 20 (03): : 215 - 220
  • [35] DNA PLOIDY LEVEL AND S-PHASE FRACTION AS PROGNOSTIC FACTORS IN BREAST-CANCER
    YOKOE, T
    IZUO, M
    ISHIDA, T
    IINO, Y
    KAWAI, T
    JAPANESE JOURNAL OF SURGERY, 1990, 20 (05): : 491 - 497
  • [36] DNA-PLOIDY AND S-PHASE FRACTION AS PROGNOSTIC FACTORS IN PATIENTS WITH UVEAL MELANOMAS
    KARLSSON, M
    BOERYD, B
    CARSTENSEN, J
    KAGEDAL, B
    WINGREN, S
    BRITISH JOURNAL OF CANCER, 1995, 71 (01) : 177 - 181
  • [37] Flow cytometry analysis of DNA ploidy, S-phase and proliferation of advanced cervix cancer
    Kravetz, O. A.
    Bogatyrev, V. N.
    ACTA CYTOLOGICA, 2007, 51 (02) : 321 - 321
  • [38] SEQUENTIAL DNA FLOW-CYTOMETRY IN METASTATIC MALIGNANT-MELANOMA
    BARTKOWIAK, D
    OTTO, F
    SCHUMANN, J
    LIPPOLD, A
    DREPPER, H
    ONCOLOGY, 1991, 48 (02) : 154 - 157
  • [39] DNA PLOIDY, S-PHASE FRACTION AND G2 FRACTION AS PROGNOSTIC DETERMINANTS IN PROSTATIC ADENOCARCINOMA
    ESKELINEN, M
    LIPPONEN, P
    MAJAPURO, R
    SYRJANEN, K
    NORDLING, S
    EUROPEAN UROLOGY, 1991, 20 (01) : 62 - 66
  • [40] TUMOR-GROWTH RATE AND DNA FLOW-CYTOMETRY PARAMETERS AS PROGNOSTIC FACTORS IN METASTATIC MELANOMA
    MUHONEN, T
    PYRHONEN, S
    LAASONEN, A
    WASENIUS, VM
    ASKOSELJAVAARA, S
    FRANSSILA, K
    KANGAS, L
    BRITISH JOURNAL OF CANCER, 1992, 66 (03) : 528 - 532